Skip to Main content Skip to Navigation
Master Thesis

Évaluation des besoins des patients atteints de myasthénie, particulièrement du point de vue du pharmacien

Abstract : Since 2004, rare diseases have become one of the priorities of the public health policy, given their significant economic impact. In parallel, promulgation of the law relative to hospital, to patient, to health and to territory, allowed the pharmacist to confirm the major role that he played or that he could play in the care of chronic diseases. By taking example on one the most frequent rare neuromuscular pathology, we are going to try to determine needs of patients affected by myasthenia gravis, and so, to estimate the role to play for the pharmacist. Our work carried on the interview of sixteen patients. Myasthenia gravis being a disease with numerous contraindicated drugs, at first, we used an optimized medicinal balance sheet that underlined the fact that, in spite of the large number of drugs at risk, the therapeutic arsenal did not turn out so reduced. In front of the multitude of the associated chronic or acute diseases, of the different consulted doctors and of the drugs at risk in this disease, the pharmacist is playing an essential role. Secondly, we tried to estimate needs of the patients, in particular concerning therapeutic education. If, until now, the pharmacist seemed to play a minor role, many patients underline in particular a need in information. So we could contribute to the quality of life of myasthenic patient, by collaborating with the doctors but also with the patients'association that seems to play an important role...
Document type :
Master Thesis
Complete list of metadata

Cited literature [25 references]  Display  Hide  Download
Contributor : Jean-Hugues Morneau Connect in order to contact the contributor
Submitted on : Monday, July 1, 2013 - 3:17:50 PM
Last modification on : Tuesday, May 11, 2021 - 11:36:16 AM
Long-term archiving on: : Wednesday, April 5, 2017 - 5:34:20 AM


  • HAL Id : dumas-00840104, version 1
  • PPN : 170406652


Aurélie Casteleyn. Évaluation des besoins des patients atteints de myasthénie, particulièrement du point de vue du pharmacien. Sciences pharmaceutiques. 2013. ⟨dumas-00840104⟩



Record views


Files downloads